MERIDIAN THERAPEUTICS Trademark

Trademark Overview


On Wednesday, January 31, 2024, a trademark application was filed for MERIDIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MERIDIAN THERAPEUTICS trademark a serial number of 98385492. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 5, 2024. This trademark is owned by Meridian Therapeutics, Inc.. The MERIDIAN THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Vaccines for human use
meridian therapeutics

General Information


Serial Number98385492
Word MarkMERIDIAN THERAPEUTICS
Filing DateWednesday, January 31, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines; Vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMeridian Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLehi, UT 84043

Trademark Events


Event DateEvent Description
Thursday, February 1, 2024NEW APPLICATION ENTERED
Sunday, June 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 26, 2024ASSIGNED TO EXAMINER
Thursday, September 5, 2024NON-FINAL ACTION E-MAILED
Thursday, September 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 5, 2024NON-FINAL ACTION WRITTEN

Related Keywords


therapeutics meridian vaccines human